The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter
Open accessAbstract
Background— Many patients with atrial fibrillation are at high risk for stroke and require antithrombotic therapy. Antiarrhythmic drugs have not previously been shown to reduce the risk of stroke in atrial fibrillation. The effect of dronedarone, a new multichannel-blocking antiarrhythmic drug, on stroke has been evaluated in a randomized, double-blind clinical trial, ATHENA (A placebo-controlled, double-blind, parallel-arm Trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter). Methods and Results— Patients with persistent or paroxysmal atrial fibrillation and at least 1 risk factor for cardiovascular hospitalization were randomized to receive dronedarone (400 mg BID) or double-blind matching placebo and followed up for a minimum of 1 year to a common termination at 30 months. All strokes that occurred during the study were included in the present post hoc analysis. There were 4628 patients randomized to placebo or dronedarone. The baseline risk factors for stroke were well balanced between the 2 groups, and the baseline mean CHADS 2 score was 2. The baseline use of either oral anticoagulant therapy or antiplatelet agent alone was 60%. Dronedarone reduced the risk of stroke from 1.8% per year to 1.2% per year (hazard ratio 0.66, 95% confidence interval 0.46 to 0.96, P =0.027). The effect of dronedarone was similar whether or not patients were receiving oral anticoagulant therapy, and there was a significantly greater effect of dronedarone in patients with higher CHADS 2 scores. Conclusions— In this post hoc analysis, a reduction in stroke was observed in patients with atrial fibrillation who were receiving usual care, which included antithrombotic therapy and heart rate control, who were randomized to dronedarone. Further studies to investigate the effect of dronedarone and other antiarrhythmic agents on stroke are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationWang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Self-citationProphylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Self-citationThe AFFIRM Investigators (2004) · Circulation · doi:10.1161/01.cir.0000121736.16643.11 · Cited by 1,206
Hohnloser, S. H., Kuck, K.-H., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,134
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationCairns, J. A., Connolly, S. J., Roberts, R., & Gent, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08171-8 · Cited by 957
Self-citationConnolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Tsang, T. S. M., Gersh, B. J., Appleton, C. P., Tajik, A. J., Barnes, M. E., Bailey, K. R., Oh, J. K., Leibson, C., Montgomery, S. C., & Seward, J. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02373-2 · Cited by 657
Clinical classification of cardiac deaths.
Hinkle, L. E., & Thaler, H. T. (1982) · Circulation · doi:10.1161/01.cir.65.3.457 · Cited by 638
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., & Hohnloser, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054686 · Cited by 631
Self-citationWattigney, W. A., Mensah, G. A., & Croft, J. B. (2003) · Circulation · doi:10.1161/01.cir.0000083722.42033.0a · Cited by 505
Waldo, A. L., Becker, R. C., Tapson, V. F., & Colgan, K. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.077 · Cited by 379
Nieuwlaat, R., Capucci, A., Lip, G. Y. H., Olsson, S. B., Prins, M. H., Nieman, F. H., Lopez-Sendon, J., Vardas, P. E., Aliot, E., Santini, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl015 · Cited by 369
Self-citationDronedarone for prevention of atrial fibrillation: A dose-ranging study
Touboul, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00321-x · Cited by 315
Morgan, C. L., McEwan, P., Tukiendorf, A., Robinson, P. A., Clemens, A., & Plumb, J. M. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2008.09.016 · Cited by 297
Lafuente-Lafuente, C., Mouly, S., Longás-Tejero, M. A., Mahé, I., & Bergmann, J.-F. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.719 · Cited by 288
Rate vs Rhythm Control in Patients With Atrial Fibrillation: A Meta-analysis
de Denus, S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.258 · Cited by 239
Davy, J.-M., Herold, M., Hoglund, C., Timmermans, A., Alings, A., Radzik, D., & Van Kempen, L. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.010 · Cited by 234
Sherman, D. G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1185 · Cited by 231
Sun, W., Sarma, J. S. M., & Singh, B. N. (1999) · Circulation · doi:10.1161/01.cir.100.22.2276 · Cited by 188
Effect of hypertension on anticoagulated patients with atrial fibrillation
Lip, G. Y. H., Frison, L., Grind, M., & on behalf of the SPORTIF Investigators (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl504 · Cited by 168
Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells
Gautier, P., Guillemare, E., Marion, A., Bertrand, J.-P., Tourneur, Y., & Nisato, D. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200302000-00007 · Cited by 127
Effects of Amiodarone and Dronedarone on Voltage‐Dependent Sodium Current in Human Cardiomyocytes
Lalevée, N., Barrère‐Lemaire, S., Gautier, P., Nargeot, J., & Richard, S. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03064.x · Cited by 99
Atrial Fibrillation: A Perspective
Wyse, D. G., & Gersh, B. J. (2004) · Circulation · doi:10.1161/01.cir.0000132611.01101.dc · Cited by 98
Wang, J., Li, Y., Franklin, S. S., & Safar, M. E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089763 · Cited by 97
Mozzicato, P. (2007) · Drug Safety · doi:10.2165/00002018-200730070-00009 · Cited by 96
Hohnloser, S. H., Connolly, S. J., Crijns, H. J. G. M., Page, R. L., Seiz, W., & Torp-Petersen, C. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01016.x · Cited by 86
Self-citationDronedarone: An Emerging Agent with Rhythm‐ and Rate‐Controlling Effects
Wegener, F., Ehrlich, J. R., & Hohnloser, S. H. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00583.x · Cited by 74
Self-citationDronedarone for prevention of atrial fibrillation: a dose-ranging study
Touboul, P., Brugada, J., Capucci, A., Crijns, N., Edvardsson, H. J. G. M., & Hohnloser, S. H. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.10.017 · Cited by 39
Self-citation
Cited by
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Kirchhof, P., Camm, A. J., Goette, A., Brandes, A., Eckardt, L., Elvan, A., Fetsch, T., van Gelder, I. C., Haase, D., Haegeli, L. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2019422 · Cited by 2,190
Self-citationWann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,336
Self-citationLenient versus strict rate control in patients with atrial fibrillation
Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033
Self-citationIncreased Mortality after Dronedarone Therapy for Severe Heart Failure
Køber, L., Torp-Pedersen, C., McMurray, J. J. V., Gøtzsche, O., Lévy, S., Crijns, H., Amlie, J., & Carlsen, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800456 · Cited by 972
Self-citationCalkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.824789 · Cited by 847
Metadata
- Authors
- Connolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H.
- Venue
- Circulation
- Published
- 2009-09-29
- Volume
- 120
- Issue
- 13
- Pages
- 1174-1180
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2090208107
- Cited by
- 261
- References
- 37
- FWCI
- 30.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.